Contrast Agents, Injectors
Total Trials
73
As Lead Sponsor
41
As Collaborator
32
Total Enrollment
94,679
NCT03910114
Gadolinium-Based-Contrast-Agents (GBCA) Enhancement During MR Urography
Phase: N/A
Role: Collaborator
Start: Jul 1, 1990
Completion: Apr 1, 2019
NCT01092754
Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Optimark (Gadoversetamide) in Pediatric Patients
Phase: Phase 4
Role: Lead Sponsor
Start: May 31, 2002
Completion: Dec 31, 2003
NCT00447889
A Clinical Study of Gadoteric Acid in Non-Coronary Magnetic Resonance (MR) Angiography
Start: Mar 31, 2006
Completion: Nov 30, 2007
NCT00347022
A Clinical Study of Xenetix 300 in Multislice Computed Tomography (CT) Pediatric Indications
Start: May 31, 2006
Completion: Jun 30, 2009
NCT00382317
A Clinical Study of Iobitridol in Patients Undergoing Multislice Computed Tomography (CT) Abdominal Angiography
Start: Aug 31, 2006
Completion: Feb 29, 2008
NCT00650845
Renal Safety Evaluation After Dotarem®-Enhanced MRI
Start: Jan 31, 2008
Completion: Aug 31, 2011
NCT01523873
Observational Post-marketing Study on the Safety and Efficacy of Dotarem® (SECURE Study)
Start: Nov 30, 2008
Completion: Jul 31, 2013
NCT00793182
Effects of Contrast Media on Subjects With Stable Reduced Renal Function Undergoing Contrast-Enhanced Computed Tomography
Start: Jan 31, 2009
NCT00811863
Evaluation of Nephrogenic Systemic Fibrosis (NSF) in Patients With Chronic Kidney Disease Following OptiMARK Injection
Start: Feb 28, 2009
Completion: May 17, 2012
NCT00845702
Renal Magnetic Resonance Angiography (MRA) Study Comparing Dotarem and Time Of Flight (TOF)
Phase: Phase 3
Start: Apr 30, 2009
Completion: Feb 28, 2010
NCT00955617
DOTAREM®-Enhanced MRA Compared to GADOVIST®-Enhanced MRA in Patients With Abdominal or Lower Limb Arterial Diseases
Start: Jul 31, 2009
Completion: Oct 31, 2010
NCT00980681
Renal Magnetic Resonance Angiography (MRA) Study Comparing Dotarem and Time-Of-Flight (TOF)
Start: Sep 30, 2009
Completion: Dec 31, 2010
NCT01010932
Carotid and Vertebral Magnetic Resonance Angiography (MRA) Study Comparing Dotarem and Time Of Flight (TOF)
Start: Oct 31, 2009
NCT01012674
NCT01026389
Efficacy Evaluation of Dotarem Compared to Gadovist in the Diagnosis of Peripheral Arterial Disease
Completion: Jan 31, 2012
NCT01254552
Assessment With CCTA and MRI in Asymptomatic Patients With Type 2 Diabetes for Detection of Unrecognized Myocardial Scar in Subclinical Coronary Atherosclerosis
Start: Aug 31, 2010
Completion: Oct 31, 2016
NCT01211873
Safety and Efficacy Evaluation of DOTAREM® in MRI of Central Nervous System (CNS) Lesions
Start: Sep 30, 2010
Completion: Nov 30, 2011
NCT01255722
Xenetix® 350: Comparative Assessment of Image Quality for Coronary CT Angiography
Start: Nov 30, 2010
Completion: Sep 30, 2012
NCT03048006
Post-marketing Surveillance Study for Evaluation of Dotarem Safety
Start: Jan 31, 2011
Completion: Dec 31, 2013
NCT01467271
Observational Study on the Incidence of NSF in Renal Impaired Patients Following Dotarem Administration
Start: May 31, 2011
Completion: Jun 30, 2017
NCT01406236
SAFE-PCI for Women
Start: Aug 31, 2011
Completion: Sep 30, 2013
NCT03041298
Post Marketing Surveillance Study for Evaluation of Efficacy and Safety of Dotarem in Magnetic Resonance Mammography
Start: Sep 30, 2011
NCT01449266
Safety and Dialysability of Dotarem® in Dialysed Patients
Phase: Phase 1
Start: Nov 30, 2011
Completion: Jun 30, 2012
NCT01482182
Predictive Value of FDG PET/CT, DWI and DCE-MRI Scans for Non-small Cell Lung Cancer Patients Receiving Chemotherapy
Completion: Jan 31, 2014
NCT01639703
Hepatic Xenetix-CT Perfusion
Start: Apr 30, 2012
Completion: Oct 31, 2014
NCT01773031
Pancreatic Duct Evaluation in Autoimmune Pancreatitis: MR Pancreatography
Start: Jan 31, 2013
Completion: Mar 31, 2015
NCT01848899
Effects Contrast on Platelet Activity, Thrombosis and Fibrinolysis in Patients Undergoing Coronary Angiography
Start: Feb 28, 2013
Completion: Nov 30, 2014
NCT01877187
Lipiodol as an Imaging Biomarker in Patients With Primary and Metastatic Liver Cancer
Phase: Phase 2
Start: Apr 30, 2013
Completion: Feb 29, 2020
NCT01853163
Long-Term Retention of Gadolinium in Bone
Start: May 6, 2013
Completion: Dec 17, 2018
NCT01806740
DCE-MRI Using Dotarem® in Evaluation of Therapeutic Response to Sorafenib in Patients With Advanced Stage HCC
Start: May 9, 2013
Completion: Oct 12, 2015
NCT03603106
Pharmacokinetics, Pharmacodynamics Profile and Tolerance of P03277 in Healthy Subjects and Patients With Brain Lesions
Phase: Phase 1/2
Start: Nov 25, 2013
Completion: Apr 17, 2015
NCT02034708
Efficacy Evaluation of Dotarem®-Enhanced MRI Compared to Gadovist®/Gadavist®-Enhanced MRI in the Diagnosis of Brain Tumors
Start: Jun 30, 2014
Completion: Sep 30, 2015
NCT02173119
Can Quantitative MRI After cTACE Help Predict Survival ?
Start: Aug 31, 2014
Completion: Mar 7, 2018
NCT02382380
Evaluation of Gadoterate in Patients With Renal Dysfunction
Start: Nov 5, 2014
Completion: Mar 20, 2024
NCT02411201
DOTAREM Pharmacokinetics and Safety Study in Pediatric Subjects Aged < 2 Years
Start: Mar 31, 2015
Completion: Oct 31, 2015
NCT02530931
Evaluation of Inner Ear and Brain Structures With Contrast-enhanced MRI in Patients With Meniere's Disease
Start: Mar 16, 2016
Completion: Sep 30, 2020
NCT02724540
Randomized Embolization Trial for NeuroEndocrine Tumor Metastases to the Liver
Start: Mar 31, 2016
Completion: Nov 8, 2024
NCT02633501
P03277 Dose Finding Study in Central Nervous System (CNS) Magnetic Resonance Imaging (MRI)
Start: Jun 30, 2016
Completion: Jan 31, 2018
NCT03057561
Efficacy of Dotarem® (Gd-DOTA) Versus Gadovist® (Gd-DO3A-butrol) for Late Gadolinium Enhancement Cardiac Magnetic Resonance
Start: Oct 1, 2016
Completion: Jun 30, 2021
NCT02973516
Proof of Concept Study Concerning Efficacy of P03277 MR Imaging in HCC Diagnosis
Start: Dec 31, 2016
Completion: Apr 4, 2019
NCT02992847
Evaluation of Potential Accumulation of Gadolinium (Dotarem and Multihance) in the French Observatory of Multiple Sclerosis (Www.Ofsep.Org/)
Start: Jan 31, 2017
Completion: Jul 31, 2017
NCT03023566
Intra-individual Open-label, Single Center Study to Compare Unenhanced MRI With Dotarem Enhanced MRI
Start: Feb 9, 2017
Completion: Nov 12, 2017
NCT03657264
Cardiac Safety Evaluation of P03277
Start: Aug 21, 2017
Completion: Jun 7, 2018
NCT03657784
Pharmacokinetics, Dialysability and Safety of P03277 in Healthy Volunteers and in Patients With Impaired Renal Function
Start: Oct 13, 2017
Completion: Aug 23, 2019
NCT02625389
A Study to Evaluate How Safe and Effective is the Mixture of Lipiodol® Ultra Fluid and Glue When Used for Embolization Procedures
Start: Nov 29, 2017
Completion: May 12, 2021
NCT03727633
Hepatocellular Carcinoma on Cirrhosis With Child A/B7 and Hepatic Intra Arterial Injection of Idarubicin/Lipiodol Emulsion
Start: Jul 19, 2018
Completion: Jan 18, 2026
NCT03749252
Pharmacokinetics, Safety and Efficacy of P03277 in Pediatric Patients Undergoing Central Nervous System Contrast-enhanced MRI
Start: Nov 6, 2018
Completion: Aug 10, 2020
NCT03731923
Abbreviated MRI for HCC Surveillance
Start: Nov 8, 2018
Completion: Dec 31, 2023
NCT03604549
Sonographic Hysterosalpingography: Oil vs Water Based Media (SHOW Trial)
Start: Jan 11, 2019
Completion: Aug 25, 2021
NCT03996447
Efficacy and Safety of Gadopiclenol for Central Nervous System (CNS) Magnetic Resonance Imaging (MRI)
Start: Jun 3, 2019
Completion: Sep 11, 2020
NCT03937921
Dotarem Evaluation for Myocardial Perfusion CMR
Start: Jul 3, 2019
Completion: Oct 31, 2024
NCT03986138
Efficacy and Safety of Gadopiclenol for Body Magnetic Resonance Imaging (MRI)
Start: Aug 27, 2019
Completion: Dec 9, 2020
NCT04341129
Abbreviated MRI Protocol: Initial Experience With Dotarem® (Gadoterate Meglumine)
Phase: Early Phase 1
Start: Jul 13, 2020
Completion: Jun 30, 2023
NCT03730051
Dotarem vs Gadobutrol Contrast for Breast MRI
Start: Mar 1, 2021
Completion: Dec 31, 2026
NCT04733092
Safety and Efficacy of a Lipiodol Emulsion for the Embolization of Hypervascularizations in Patients With Knee Pain (LipioJoint1)
Start: Mar 3, 2021
Completion: Sep 20, 2022
NCT04373564
Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
Start: Mar 24, 2021
Completion: Dec 31, 2028
NCT04906005
Pharmacokinetics and Safety of Gadopiclenol in Japanese Healthy Volunteers
Start: May 10, 2021
Completion: Jul 27, 2021
NCT04928092
A Zero Acute Kidney Injury Strategy for Percutaneous Coronary Intervention in Patients With ChronicKidney Disease
Start: Jan 31, 2022
Completion: Mar 31, 2023
NCT05248308
Genicular Artery Embolization (GAE) for the Treatment of Chronic Post Knee Arthroplasty Pain
Start: Jul 1, 2022
Completion: Sep 1, 2023
NCT05316077
Safety and Performance of Vectorio® in Conventional Trans-Arterial Chemo-Embolization (cTACE): A Post-Market Clinical Follow-up
Start: Aug 30, 2022
NCT05590884
Gadopiclenol Pharmacokinetics, Safety and Efficacy in Children < 2 Years of Age
Start: Sep 21, 2022
Completion: Sep 30, 2024
NCT05537779
Safety and Performance of Optivantage Multi-use When Injecting Contrast Media for Contrast Enhanced CT Examination
Start: Oct 31, 2022
Completion: Jan 31, 2023
NCT06114082
TACE Using Idarubicin Versus Doxorubicin Chemoemulsion in Patients with Hepatocellular Carcinoma
Start: Apr 28, 2023
Completion: Jun 30, 2026
NCT06010173
Evaluation of Gadopiclenol for Magnetic Resonance Imaging (MRI) in Japanese Adults and Children
Start: Jul 21, 2023
Completion: Mar 26, 2025
NCT06057168
Performance of Elucirem® in DSC-MRI Perfusion of Brain Gliomas
Start: Sep 7, 2023
Completion: Nov 28, 2024
NCT05490381
Preoperative Embolization of Hypervascular Head and Neck Tumors to Improve Surgical Outcomes
Start: Dec 21, 2023
Completion: Jan 31, 2025
NCT06226129
Gadopiclenol in Contrast Enhanced MRI of the Prostate
Start: Feb 14, 2024
Completion: Feb 1, 2028
NCT06703450
Guerbet Liver Fibrosis
Start: Feb 28, 2024
Completion: Feb 28, 2026
NCT06596616
Gadopiclenol vs Gadoxetate MRI for Liver Lesions
Start: Jul 1, 2024
Completion: Mar 27, 2026
NCT06563908
Lipiodol Prior to FET (LIFE)
Start: Aug 10, 2024
NCT06127810
MRI Gadopiclenol Enhanced Imaging of CNS Tumors
Start: Dec 30, 2024
Completion: Dec 30, 2024
NCT05954559
High Relaxivity Contrast Agent for Cardiac MR in the Myocardial Scar Assessment
Start: Aug 1, 2025
Completion: Apr 30, 2026
NCT07083115
Developing MRI Technologies for Atrial Fibrillation
Start: Sep 30, 2025
Completion: Sep 30, 2028
Loading map...